フォロー
Hiroshi Nomoto
Hiroshi Nomoto
Hokkaido University Hospital, Diabetes and Endocrinology
確認したメール アドレス: med.hokudai.ac.jp
タイトル
引用先
引用先
HLA-DQB1* 03: 01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors
H Ujiie, K Muramatsu, T Mushiroda, T Ozeki, H Miyoshi, H Iwata, ...
The Journal of investigative dermatology 138 (5), 1201-1204, 2018
1182018
IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
C Montemurro, H Nomoto, L Pei, VS Parekh, KE Vongbunyong, ...
Nature communications 10 (1), 2679, 2019
722019
IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
C Montemurro, H Nomoto, L Pei, VS Parekh, KE Vongbunyong, ...
Nature communications 10 (1), 2679, 2019
722019
IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
C Montemurro, H Nomoto, L Pei, VS Parekh, KE Vongbunyong, ...
Nature communications 10 (1), 2679, 2019
722019
IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function
C Montemurro, H Nomoto, L Pei, VS Parekh, KE Vongbunyong, ...
Nature communications 10 (1), 2679, 2019
722019
Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy
C Yamamoto, H Miyoshi, K Ono, H Sugawara, R Kameda, M Ichiyama, ...
Endocrine journal 63 (6), 589-596, 2016
632016
Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes
H Nomoto, L Pei, C Montemurro, M Rosenberger, A Furterer, G Coppola, ...
Diabetologia 63, 149-161, 2020
552020
A comparison of the effects of the GLP-1 analogue liraglutide and insulin glargine on endothelial function and metabolic parameters: a randomized, controlled trial Sapporo …
H Nomoto, H Miyoshi, T Furumoto, K Oba, H Tsutsui, A Miyoshi, T Kondo, ...
PloS one 10 (8), e0135854, 2015
532015
A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes …
H Nomoto, H Miyoshi, H Sugawara, K Ono, S Yanagiya, M Oita, ...
Diabetology & Metabolic Syndrome 9, 1-9, 2017
412017
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: a randomized controlled trial
T Takase, A Nakamura, C Yamamoto, H Nomoto, A Miya, M Dannoura, ...
Journal of Diabetes Investigation 10 (3), 699-705, 2019
382019
A randomized controlled trial comparing the effects of sitagliptin and glimepiride on endothelial function and metabolic parameters: Sapporo Athero-Incretin Study 1 (SAIS1)
H Nomoto, H Miyoshi, T Furumoto, K Oba, H Tsutsui, A Inoue, T Atsumi, ...
PloS one 11 (10), e0164255, 2016
382016
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
N Kitao, H Miyoshi, T Furumoto, K Ono, H Nomoto, A Miya, C Yamamoto, ...
Cardiovascular Diabetology 16 (1), 125, 2017
372017
Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus
A Miyoshi, S Nagai, M Takeda, T Kondo, H Nomoto, H Kameda, A Hirai, ...
Journal of diabetes investigation 4 (3), 326-329, 2013
332013
Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus
C Yamamoto, H Miyoshi, Y Fujiwara, R Kameda, M Ichiyama, H Nomoto, ...
Endocrine journal 63 (1), 53-60, 2016
312016
Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone
KY Cho, A Nakamura, K Omori, T Takase, A Miya, K Yamamoto, ...
Journal of Diabetes Investigation 12 (7), 1272-1277, 2021
292021
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice
K Omori, A Nakamura, H Miyoshi, K Takahashi, N Kitao, H Nomoto, ...
Metabolism 98, 27-36, 2019
292019
Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
K Takahashi, A Nakamura, H Miyoshi, H Nomoto, N Kitao, K Omori, ...
Scientific reports 8 (1), 6864, 2018
272018
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
K Omori, H Nomoto, A Nakamura, T Takase, KY Cho, K Ono, N Manda, ...
Journal of Diabetes Investigation 10 (2), 367-374, 2019
232019
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
K Omori, H Nomoto, A Nakamura, T Takase, KY Cho, K Ono, N Manda, ...
Journal of Diabetes Investigation 10 (2), 367-374, 2019
232019
IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes
M Blencowe, A Furterer, Q Wang, F Gao, M Rosenberger, L Pei, ...
Diabetologia 65, 173-187, 2022
222022
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20